Qlaris Bio
Highly Engaged Employees
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
770 Legacy Pl Fl 2, Dedham, Massachusett...Website
qlaris.bioRevenue
<$5 MillionIndustry
About Qlaris Bio
Qlaris Bio is a clinical-stage biotechnology company dedicated to developing innovative first-in-class therapies aimed at treating serious ophthalmic diseases, particularly glaucoma. Their lead product, QLS-111, targets intraocular pressure through a unique mechanism of action, offering potential advantages over existing treatments. The company focuses on addressing significant unmet needs in ophthalmology, including conditions like Primary Open-Angle Glaucoma and Ocular Hypertension. Qlaris Bio's commitment is to preserve vision and prevent blindness for patients suffering from debilitating eye conditions.Explore more
SIC Code 28,283NAICS Code 32,325Show moreQlaris Bio Org Chart
Compare Similar Companies to Qlaris Bio
Compare insights from companies similar to Qlaris Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Qlaris Bio Tech Stack
A closer look at the technologies used by Qlaris Bio
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Qlaris Bio
Sign Up For FreeTo access detailed company insights
Qlaris Bio is a clinical-stage biotechnology company dedicated to developing innovative first-in-class therapies aimed at treating serious ophthalmic diseases, particularly glaucoma. Their lead product, QLS-111, targets intraocular pressure through a unique mechanism of action, offering potential advantages over existing treatments. The company foc... Read More
